Valley Medical Pharmacy 
630 Main Street 
Brawley, CA 92227 
eRx ID#0585957 
1 (800) 322-0808 | Toll Free Fax: 1 (855) 322-0808 
Email: drugsdepot@yahoo.com 
Web: www.drugsdepot 
Timing: Monday to Friday | 9:00 AM to 5:45 PM 


Nimodipine 30 Mg 100 Unit Dose Caps By Heritage Pharma

Image 0 of Nimodipine 30 Mg 100 Unit Dose Caps By Heritage Pharma Image 1 of Nimodipine 30 Mg 100 Unit Dose Caps By Heritage Pharma

Nimodipine 30 Mg 100 Unit Dose Caps By Heritage Pharma

Call for Price

Nimodipine 30 Mg 100 Unit Dose Caps By Heritage Pharma This Item Requires A Valid Order From A Physician Licensed in USA. Item Number.:RXD4083085/RXB10041184
Size : 100
Selling UoM : EA
NDC: 23155-0108-00
UPC Barcode : 323155108002
Supplier: 0050001582 HERITAGE PHARMACEUTICALS INC
Supplier Material : 010800
Generic Code : 000579 NIMODIPINE ORAL CAPSULE 30 MG
Fine Line Class : 850085008510 All Rx Products
Product Category : RX Pharmaceuticals
Product Type : GRX Generic

Have a question?

  Call for Price

Product Description.:

H108
capsule , white , oblong oblong
Black inkOpaque

DO NOT ADMINISTER NIMOTOP INTRAVENOUSLY OR BY OTHER PARENTERAL ROUTES. DEATHS AND SERIOUS, LIFE THREATENING ADVERSE EVENTS HAVE OCCURRED WHEN THE CONTENTS OF NIMOTOP CAPSULES HAVE BEEN INJECTED PARENTERALLY (See WARNINGS and DOSAGE AND ADMINISTRATION).
DRUG DESCRIPTION

Nimotop? (nimodipine) belongs to the class of pharmacological agents known as calcium channel blockers.

Nimodipine is a yellow crystalline substance, practically insoluble in water.

NIMOTOP? capsules are formulated as soft gelatin capsules for oral administration. Each liquid filled capsule contains 30 mg of nimodipine in a vehicle of glycerin, peppermint oil, purified water and polyethylene glycol 400. The soft gelatin capsule shell contains gelatin, glycerin, purified water and titanium dioxide.

INDICATIONS

Nimotop? (nimodipine) is indicated for the improvement of neurological outcome by reducing the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage from ruptured intracranial berry aneurysms regardless of their post-ictus neurological condition (i.e., Hunt and Hess Grades I-V).

SIDE EFFECTS

Adverse experiences were reported by 92 of 823 patients with subarachnoid hemorrhage (11.2%) who were given nimodipine. The most frequently reported adverse experience was decreased blood pressure in 4.4% of these patients. Twenty-nine of 479 (6.1%) placebo treated patients also reported adverse experiences. The events reported with a frequency greater than 1% are displayed below by dose.